Literature DB >> 31299195

LMP1-miR-146a-CXCR4 axis regulates cell proliferation, apoptosis and metastasis.

Weiwen Wang1, Yan Zhang2, Wen Liu3, Hua Xiao4, Qianqian Zhang5, Jiayi Wang6, Bing Luo7.   

Abstract

Epstein-Barr virus (EBV), the first human tumor virus to have been discovered, sustains an asymptomatic lifelong infection in ∼95% of the world's population. Reportedly, EBV infection induces the expression of specific cellular microRNAs (miRNAs), such as miR-155, miR-146a, miR-21, which can contribute to the persistence of latently infected cells. In this study, we investigated whether C-X-C chemokine receptor type 4 (CXCR4) is a cellular target of human miR-146a. We also investigated the role of miR-146a and CXCR4 in EBV-associated cells. The results indicate that miR-146a is more abundantly expressed in EBV-positive than in EBV-negative cells. MiR-146a down-regulated CXCR4 expression in a dose- and time-dependent manner. Phenotypic experiments detected miR-146a mimics that could suppress cell proliferation and cell migration and promote cell apoptosis by targeting CXCR4. In addition, miR-146a mimics suppressed cell survival by decreasing the population of G0/G1 phase cells. Latent membrane protein (LMP)1, an importance oncoprotein, can stimulate miR-146a and inhibit the CXCR4 expression. Our findings indicate that LMP1-miR-146a-CXCR4 axis functions as a regulator in the EBV-associated cells.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CXCR4; LMP1; miR-146a

Year:  2019        PMID: 31299195     DOI: 10.1016/j.virusres.2019.197654

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

1.  The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells.

Authors:  Mei Zeng; Yuhua Chen; Xintao Jia; Yan Liu
Journal:  Cancer Manag Res       Date:  2020-09-22       Impact factor: 3.989

Review 2.  The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.

Authors:  Géraldine Schlecht-Louf; Claire Deback; Françoise Bachelerie
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

Review 3.  Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy.

Authors:  Ruogang Zhao; Jianhao Liu; Zhaohuan Li; Wenhui Zhang; Feng Wang; Bo Zhang
Journal:  Pharmaceutics       Date:  2022-07-25       Impact factor: 6.525

Review 4.  The Emerging Role of Non-Coding RNAs in the Regulation of Virus Replication and Resultant Cellular Pathologies.

Authors:  Soudeh Ghafouri-Fard; Bashdar Mahmud Hussen; Hazha Hadayat Jamal; Mohammad Taheri; Guive Sharifi
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.